Response to the correspondence: “Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma”
- Resource Type
- Correspondence
- Source
- In
Respiratory Medicine January 2022 191 - Subject
- Language
- ISSN
- 0954-6111